Company Overview and News

 
04-21-2018 - Lynn Stout, RIP, Sparred With Charlie Munger

2018-04-22 archive.aweber
Charlie Munger met his match in Lynn Stout. Mr. Munger, Warren Buffett’s best friend since 1959, is a notoriously fierce debater who does not suffer fools gladly. At a symposium on The Essays of Warren Buffett I hosted in 1996, […]
Upvote Downvote

 
Canadian Toys “R” Us stores find a buyer in Fairfax Financial Holdings

2018-04-20 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Toys 'R' Us Canada draws $300M 'stalking horse' bid from Fairfax Financial

2018-04-20 cbc.ca
Ahead of an auction scheduled next week for the Canadian assets of Toys "R" US, Fairfax Financial Holdings Ltd. has put in a $300-million offer.
Upvote Downvote

 
What A Difference 3 Months Makes In Hedge Fund Land!

2018-04-20 archive.mlgngo
Want market-beating yield in today's zero-interest world? The right dividend stocks could boost your returns 345%.
Upvote Downvote

 
PRESS DIGEST- Canada-April 20

2018-04-20 reuters
April 20 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
Fairfax Agrees to Purchase Toys ‘R’ Us Canadian Unit - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
FXFLF / Fairfax Financial Holdings Ltd. 6-K (Current Report of Foreign Issuer)

2018-04-20 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Upvote Downvote

 
Prem Watsa: Creating Fairfax Financial, Long Term Investing And Culture

2018-04-19 valuewalkpremium
A speech and Q&A with billionaire value investor and founder of Fairfax Financial Holdings, Prem Watsa. In this speech, Prem discusses starting Fairfax and coming to Canada. Prem also talks about long term investing, Fairfax’s culture and principles.
Upvote Downvote

 
Fairfax Announces Conference Call

2018-04-19 globenewswire
TORONTO, April 19, 2018 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX:FFH) (TSX:FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, May 4, 2018 to discuss its 2018 first quarter results which will be announced after the close of markets on Thursday, May 3 and will be available at that time on its website www.fairfax.ca. The call, consisting of a presentation by the company followed by a question period, may be accessed at (800) 857-9641 (Canada and U.
Upvote Downvote

 
Coverfox gets $22 million funding from Transamerica, others

2018-04-18 livemint
Bengaluru: Glitterbug Technologies Pvt. Ltd, which owns online insurance platform Coverfox, has raised $22 million in a Series C funding round led by International Finance Corp. (IFC), the investment arm of the World Bank Group, and existing investor Transamerica.
Upvote Downvote

 
Fairfax Completes US$600 Million Senior Notes Offering

2018-04-17 globenewswire
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX:FFH) (TSX:FFH.U) has completed its previously announced offering of US$600 million in aggregate principal amount of 4.850% Senior Notes due 2028 (the “Notes”). In anticipation of the offering of the Notes, Fairfax initiated a hedge of the treasury benchmark related to the Notes. After giving effect to the benefit of this hedge, the effective interest rate on the Notes is 4.
Upvote Downvote

1
4 Well-Covered Preferreds Yielding Over 8%: No K-1, All Going Ex-Dividend Soon

2018-04-15 seekingalpha
They're all cumulative, and 3 of 4 are selling below their $25 call value - the 4th is at $25.03.
Upvote Downvote

 
Fairfax Announces Pricing of Senior Notes Offering

2018-04-13 globenewswire
TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX:FFH) (TSX:FFH.U) announces that it has priced its previously announced private offering of US$600,000,000 of Fairfax’s Senior Notes due 2028 (the “Notes”) at an issue price of 99.765%. The Notes will be unsecured obligations of Fairfax and will pay a fixed rate of interest of 4.850% per annum. In anticipation of the offering of the Notes, Fairfax initiated a hedge of the treasury benchmark related to the Notes.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 303901508